about
Association of Myeloperoxidase and the Atherogenic Index of Plasma in Children with End-Stage Renal Disease.The Pleiotropic Effects of Atorvastatin on Stable Angina Patients: Evidence by Analysis of High-Density Lipoprotein Size and Subclasses, and Plasma mRNA.Atherogenic dyslipidemia and oxidative stress: a new look.Can non-cholesterol sterols and lipoprotein subclasses distribution predict different patterns of cholesterol metabolism and statin therapy response?Relationship Between the Apolipoprotein E Genotype and LDL Particle Size in Patients With Obstructive Sleep Apnea.Oxidative stress and hemoglobin-cholesterol adduct in renal patients with different LDL phenotypes.Effects of rosiglitazone on fasting and postprandial low- and high-density lipoproteins size and subclasses in type 2 diabetes.Protective role of glutathione reductase in paraquat induced neurotoxicity.Smaller HDL particles are associated with absence of obstructive coronary artery disease in stable angina pectoris patients.Distribution of low-density lipoprotein and high-density lipoprotein subclasses in patients with sarcoidosis.Small, dense LDL cholesterol and apolipoprotein B: relationship with serum lipids and LDL size.Associations of Apgar score and size at birth with lipoprotein subclasses in juvenile obesityPreanalytical and analytical challenges in gas chromatographic determination of cholesterol synthesis and absorption markers.Effects of co-existing autoimmune diseases on serum lipids and lipoprotein subclasses profile in paediatric patients with type 1 diabetes mellitus.The usefulness of advanced lipid and oxidative stress testing for diagnosis and management of low HDL-cholesterol phenotype: A case report.Hypertension, lipoprotein subclasses and lipid transfer proteins in obese children and adolescents.Higher circulating resistin protein and PBMCs resistin mRNA levels are associated with increased prevalence of small dense LDL particles in coronary artery disease patients.Interrelated cathepsin S-lowering and LDL subclass profile improvements induced by atorvastatin in the plasma of stable angina patients.Significance of LDL and HDL subclasses characterization in the assessment of risk for colorectal cancer developmentEvaluation of a Summary Score for Dyslipidemia, Oxidative Stress and Inflammation (the Doi Score) in Women with Polycystic Ovary Syndrome and its Relationship with ObesityAssociation of glutathione-S-transferase gene polymorphism and lipoprotein subclasses in hemodialysis patientsLDL and HDL subclasses and their relationship with Framingham risk score in middle-aged Serbian populationGender-related effect of apo E polymorphism on lipoprotein particle sizes in the middle-aged subjectsCombined effects of small apolipoprotein (a) isoforms and small, dense LDL on coronary artery disease riskCox proportional hazard model analysis of survival in end-stage renal disease patients with small-sized high-density lipoprotein particlesCharacteristics of low-density and high-density lipoprotein subclasses in pediatric renal transplant recipientsAssociation of small, dense low-density lipoprotein cholesterol and galectin-3 in patients with chronic kidney diseaseAssociation of Dyslipidemia, Oxidative Stress, and Inflammation With Redox Status in VLDL, LDL, and HDL Lipoproteins in Patients With Renal DiseaseChanges in lecithin: cholesterol acyltransferase, cholesteryl ester transfer protein and paraoxonase-1 activities in patients with colorectal cancerAlterations of HDL Particles in Children with End-stage Renal DiseaseActivity of paraoxonase 1 (PON1) on HDL2 and HDL3 subclasses in renal diseaseThe Potential Importance of Paraoxonase-1 in Surgical PatientsThe association between lecithin-cholesterol acyltransferase activity and fatty liver indexParaoxonase 1 and atherosclerosis-related diseasesAssociation of acute Babesia canis infection and serum lipid, lipoprotein, and apoprotein concentrations in dogsAssociation among resistin, adenylate cyclase-associated protein 1 and high-density lipoprotein cholesterol in patients with colorectal cancer: a multi-marker approach, as a hallmark of innovative predictive, preventive, and personalized medicineObesity and dyslipidemiaAssociation between proprotein convertase subtilisin/kexin 9 (PCSK9) and lipoprotein subclasses in children with type 1 diabetes mellitus: Effects of glycemic control
P50
Q33801107-C8F0FC23-29C6-4668-9E4F-7C712A9C4AE4Q37041300-448FF192-9095-4896-ABC2-321BB68497E3Q37449928-280A68B4-07AF-4EAF-A1F8-791DE39F5C99Q38813500-E1548E56-BC40-422C-B17C-661459D1DABAQ39949052-00DB01B8-7C7F-4271-AD7A-3A189B34A13CQ40652538-EB2DED63-2281-4C50-9924-554E8E09FC5EQ42169796-25B00750-9D05-455D-9EA4-A690F8A99F22Q42717341-92889BB6-66EC-44A3-A3EB-3C00576E57DBQ44993872-B8C8195F-A14D-4377-95E1-261664074AD2Q45216924-A2721F70-BD35-42CC-B99F-950037529302Q45919762-7BDB26BF-D55B-4CB5-8BEE-CC6247872C38Q47172235-5CCD598D-B4C9-4DC7-BE82-373B662FF751Q49601979-B0E41EE3-C8A6-4003-ABF9-7D648C180477Q50149020-455A7F9C-E08C-4913-B77B-2FE35E908921Q50925014-16B47502-A3A6-4858-8C2B-89782FE726EDQ51662762-7ABDCE01-C76D-4CB0-8050-F22A5A375C38Q53317238-6154E65B-D1D1-4AF9-A990-2A87236EF7AFQ54213436-F363FA79-2DF1-4929-854F-34B24754865DQ59133706-51A52EB2-89FE-435D-9647-0B3AF71C3A60Q60309679-79692A3E-076C-45D9-8507-F15ED462673CQ62747426-D99F2210-BCF1-4E9D-B957-C717961E3F51Q79754245-D1915ACF-D33C-4F73-A2A0-1339046AC239Q80216204-0E649699-CEA7-4503-86AE-60C1C272AC67Q82872960-57829743-CF67-4C91-ADC5-ED1559ADFCBCQ83409956-3CCB05B5-4030-419A-B861-93D2504DFFF8Q84781690-2626A562-849C-4EEC-B728-F752DAAB8659Q88140284-7771D001-1D85-47FC-98D9-E269B3459ACAQ89127725-450B88D1-4A34-48E0-BF68-52B675EBEF8EQ89998589-5966FFE6-9A81-4E3A-B875-F44883338184Q90728627-215E8473-FF91-4B04-A7B5-67107388FC89Q91063736-9A887371-F1B8-4B56-AA70-82A9DB89D173Q91646945-E68976B1-E176-4DAA-BCD1-5171294F1A6FQ91986618-E761C901-FF9F-4D00-B4C8-713918D6FC73Q92538887-108E0CA9-E0E6-496B-8283-0505F9C4ADADQ92598907-22E98A92-EFE2-4885-A043-B20A4EB17745Q92967254-F39C20D7-AD26-43D2-AB04-1997C647C1C4Q93187061-770EF8E2-E0CE-4329-9A95-FBE70192DE9CQ93213658-A962CECB-564D-4BA8-AFC6-1FD00B6634C7
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jelena Vekic
@ast
Jelena Vekic
@en
Jelena Vekic
@es
Jelena Vekic
@nl
type
label
Jelena Vekic
@ast
Jelena Vekic
@en
Jelena Vekic
@es
Jelena Vekic
@nl
prefLabel
Jelena Vekic
@ast
Jelena Vekic
@en
Jelena Vekic
@es
Jelena Vekic
@nl
P106
P1153
16023232500
P31
P496
0000-0001-7445-0504